Estimated life expectancy: integration of age and comorbidities

feature-image

Play all audios:

Loading...

Most guidelines recommend integration of estimated life expectancy into the routine decision-making process in prostate cancer treatment. This article underlines the use of both age and


comorbidities to calculate life expectancy, which is highly dependent on the health status of the individual patient. Access through your institution Buy or subscribe This is a preview of


subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $209.00 per year only


$17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout


ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support REFERENCES * Gupta, M. _ et al_. Clinical practice guidelines on


prostate cancer: a critical appraisal. _J. Urol._ 193, 1153–1158 (2015). Article  Google Scholar  * Heidenreich, A. _ et al_. Early detection of prostate cancer: European Association of


Urology recommendation. _Eur. Urol._ 64, 347–354 (2013). Article  Google Scholar  * Walz, J. _ et al_. Clinicians are poor raters of life-expectancy before radical prostatectomy or


definitive radiotherapy for localized prostate cancer. _BJU_ _Int._ 100, 1254–1258 (2007). Google Scholar  * Daskivich, T. J., Wood, L., Skarecky, D., Ahlering, T. & Freedland, S.


Limitations of the National Comprehensive Cancer Network guidelines for prediction of limited life expectancy in men with prostate cancer. _J. Urol._


http://dx.doi.org/10.1016/j.juro.2016.08.096 (2016). * Daskivich, T. J. _ et al_. Comorbidity and competing risks for mortality in men with prostate cancer. _Cancer._ 117, 4642–4650 (2011).


Article  Google Scholar  * Lunardi, P. _ et al_. Current impact of age and comorbidity assessment on prostate cancer treatment choice and over/undertreatment risk. _World J. Urol._


http://dx.doi.org/10.1007/s00345-016-1900-9 (2016). * Jespersen, C. G., Nørgaard, M., Jacobsen, J. B. & Borre, M. Patient comorbidity is associated with conservative treatment of


localized prostate cancer. _Scand. J. Urol._ 49, 366–370 (2015). Article  CAS  Google Scholar  * Froehner, M. _ et al_. A combined index to classify prognostic comorbidity in candidates for


radical prostatectomy. _BMC Urol._ http://dx.doi.org/10.1186/1471-2490-14-28 (2014). * O'Doherty, M. G. _ et al_. Effect of major lifestyle risk factors, independent and jointly, on


life expectancy with and without cardiovascular disease: results from the Consortium on Health and Ageing Network of Cohorts in Europe and the United States (CHANCES). _Eur. J. Epidemiol._


31, 455–468 (2016). Article  Google Scholar  * Daskivich, T. J. _ et al_. Questioning the 10-year life expectancy rule for high-grade prostate cancer: comparative effectiveness of aggressive


versus nonaggressive treatment of high-grade disease in older men with differing comorbid disease burdens. _Urology_ 93, 68–76 (2016). Article  Google Scholar  Download references AUTHOR


INFORMATION AUTHORS AND AFFILIATIONS * Axel Heidenreich and David Pfister are at the Department of Urology, Uro-Oncology, Robot-Assisted and Reconstructive Urologic Surgery, University


Hospital Cologne, Kerpener Straße 62, 50937 Köln, Germany., Axel Heidenreich & David Pfister Authors * Axel Heidenreich View author publications You can also search for this author


inPubMed Google Scholar * David Pfister View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to Axel Heidenreich. ETHICS


DECLARATIONS COMPETING INTERESTS The authors declare no competing financial interests. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Heidenreich, A.,


Pfister, D. Estimated life expectancy: integration of age and comorbidities. _Nat Rev Urol_ 13, 634–635 (2016). https://doi.org/10.1038/nrurol.2016.203 Download citation * Published: 18


October 2016 * Issue Date: November 2016 * DOI: https://doi.org/10.1038/nrurol.2016.203 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get


shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative